Clot Warnings Urged as J&J Vaccine Liability Shield Stays Strong

Health providers administering Johnson & Johnson’s Covid-19 shot still have robust protection from liability for adverse effects after the nationwide pause, even if they don’t pass out updated fact sheets detailing the risk of rare blood clots.

It’s a high bar to sidestep the immunity shields granted under a 2005 public readiness law, which safeguards vaccine makers, administrators, and other entities from lawsuits unless there’s willful misconduct, attorneys say.

Still, giving a verbal warning along with a written one is likely a best practice for providers as the U.S. vaccination effort continues.

“The combination of public information and the fact ...